Karine Celli‐Lebras

1.8k total citations
16 papers, 347 citations indexed

About

Karine Celli‐Lebras is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Karine Celli‐Lebras has authored 16 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Karine Celli‐Lebras's work include Acute Myeloid Leukemia Research (16 papers), Cancer Genomics and Diagnostics (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Karine Celli‐Lebras is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Cancer Genomics and Diagnostics (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Karine Celli‐Lebras collaborates with scholars based in France and United States. Karine Celli‐Lebras's co-authors include Claude Preudhomme, Hervé Dombret, Nicolas Boissel, Aline Renneville, Alice Marceau‐Renaut, Sandrine Geffroy, Nicolas Duployez, Christine Terré, Maxime Bucci and Jean‐Baptiste Micol and has published in prestigious journals such as Journal of Clinical Oncology, Blood and BMC Bioinformatics.

In The Last Decade

Karine Celli‐Lebras

15 papers receiving 343 citations

Peers

Karine Celli‐Lebras

HEMAT

GENET

PHEOH

Maria C. Sauerland Germany

Maria Paz Queipo De Llano Spain

A Dufour Germany

Harmony Leroy France

Ina Stolze Germany

Gudrun Mellert Germany

Zinia J. Kwidama Netherlands

S-J Wu Taiwan

Ιoannis Kakkas Greece

Yen-Ning Huang South Korea

Maria C. Sauerland Germany

Karine Celli‐Lebras

424 ×1.4

HEMAT

175 ×1.1

124 ×1.3

GENET

121 ×1.4

PHEOH

69 ×1.0

Citations per year, relative to Karine Celli‐Lebras Karine Celli‐Lebras (= 1×) peers Maria C. Sauerland

Countries citing papers authored by Karine Celli‐Lebras

Since Specialization

Citations

This map shows the geographic impact of Karine Celli‐Lebras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Celli‐Lebras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Celli‐Lebras more than expected).

Fields of papers citing papers by Karine Celli‐Lebras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Celli‐Lebras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Celli‐Lebras. The network helps show where Karine Celli‐Lebras may publish in the future.

Co-authorship network of co-authors of Karine Celli‐Lebras

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Celli‐Lebras. A scholar is included among the top collaborators of Karine Celli‐Lebras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Celli‐Lebras. Karine Celli‐Lebras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hirsch, Pierre, Jérôme Lambert, Maxime Bucci, et al.. (2024). Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study. Blood Cancer Journal. 14(1). 97–97. 3 indexed citations

Fenwarth, Laurène, Jérôme Lambert, Stéphane de Botton, et al.. (2023). LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood Advances. 7(15). 4024–4034. 4 indexed citations

Duployez, Nicolas, Martin Figeac, Sandrine Geffroy, et al.. (2022). Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r. BMC Bioinformatics. 23(1). 448–448.

Fenwarth, Laurène, Nicolas Duployez, Claude Gardin, et al.. (2022). Prognostic Impact of Monoallelic Versus Biallelic TP53 Alterations in Intensively-Treated Adults AML Patients: A Retrospective Study from the ALFA Group. Blood. 140(Supplement 1). 737–738. 5 indexed citations

Lambert, Juliette, Jérôme Lambert, Xavier Thomas, et al.. (2021). Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML. Blood Advances. 5(23). 5258–5268. 17 indexed citations

Fenwarth, Laurène, Nicolas Duployez, Xavier Thomas, et al.. (2019). Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype. Cancers. 12(1). 88–88. 5 indexed citations

Duployez, Nicolas, Christophe Roumier, Nicolas Boissel, et al.. (2018). SNP-array lesions in core binding factor acute myeloid leukemia. Oncotarget. 9(5). 6478–6489. 10 indexed citations

Boissel, Nicolas, Nathalie Hélevaut, Jordan Madic, et al.. (2018). Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group. Haematologica. 103(5). 822–829. 34 indexed citations

Duployez, Nicolas, Alice Marceau‐Renaut, Nicolas Boissel, et al.. (2016). Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood. 127(20). 2451–2459. 150 indexed citations

10.

Smol, Thomas, Olivier Nibourel, Alice Marceau‐Renaut, et al.. (2015). Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group. Leukemia Research. 39(12). 1443–1447. 9 indexed citations

11.

Thomas, Xavier, Stéphane de Botton, Sylvie Chevret, et al.. (2015). Clofarabine-Based Consolidation Improves Relapse-Free Survival of Younger Adults with Non-Favorable Acute Myeloid Leukemia (AML) in First Remission: Results of the Randomized ALFA-0702/Clara Study (NCT 00932412). Blood. 126(23). 218–218. 3 indexed citations

12.

Duployez, Nicolas, Olivier Nibourel, Alice Marceau‐Renaut, et al.. (2014). Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1‐RUNX1T1 fusion quantification on genomic DNA. American Journal of Hematology. 89(6). 610–615. 18 indexed citations

13.

Duployez, Nicolas, Aline Renneville, Olivier Nibourel, et al.. (2013). Minimal Residual Disease Monitoring In t(8;21) Acute Myeloid Leukemia Based On RUNX1-RUNX1T1 Fusion Quantification On Genomic DNA. Blood. 122(21). 1353–1353. 1 indexed citations

14.

Sarkozy, Clémentine, Claude Gardin, Nathalie Gachard, et al.. (2013). Outcome of older patients with acute myeloid leukemia in first relapse. American Journal of Hematology. 88(9). 758–764. 39 indexed citations

15.

Gardin, Claude, Sylvie Chevret, Cécile Pautas, et al.. (2012). Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older. Journal of Clinical Oncology. 31(3). 321–327. 48 indexed citations

16.

Sarkozy, Clémentine, Claude Gardin, Nathalie Gachard, et al.. (2011). Older Patients with Acute Myeloid Leukemia (AML) in First Relapse: Impact of Genetics and of Salvage Therapy. A Study of the Acute Leukemia French Association (ALFA). Blood. 118(21). 253–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact